Beijing Foyou Pharma CO.,LTD (SHA:601089)

SHA:601089 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,512	794.07	2,531	2,541	434.69	270.24
Trading Asset Securities	511	1,579	-	-	100	50
Cash & Short-Term Investments	2,023	2,373	2,531	2,541	534.69	320.24
Cash Growth	-12.10%	-6.23%	-0.41%	375.27%	66.97%	-30.82%
Accounts Receivable	428.14	354.66	346.13	396.47	337.99	374.95
Other Receivables	1.5	98.63	100.23	74.77	57.66	47.21
Receivables	429.64	453.28	446.37	471.24	395.65	422.16
Inventory	360.24	347.56	307.42	339.1	324	276.96
Other Current Assets	54.87	27.26	44.14	20.79	25.08	54.48
Total Current Assets	2,867	3,201	3,329	3,372	1,279	1,074
Property, Plant & Equipment	1,641	1,426	983.41	779.77	721.73	564.43
Other Intangible Assets	138.54	139.21	150.2	142.61	144.24	53.77
Long-Term Deferred Tax Assets	3.02	3.31	2.81	4.72	4.39	4.45
Long-Term Deferred Charges	17.52	21.82	22.92	17.65	0.33	0.69
Other Long-Term Assets	23.42	25.34	59.71	4.86	3.08	5.86
Total Assets	4,691	4,817	4,548	4,322	2,153	1,703
Accounts Payable	231.57	286.76	132.18	143.51	129.77	92.89
Accrued Expenses	639.39	676.84	607.02	598.17	472.26	335
Short-Term Debt	-	40.03	55.05	40.05	70.09	48.26
Current Portion of Long-Term Debt	-	-	4.95	4.95	7.01	35.51
Current Portion of Leases	18.37	14.33	19.66	16.26	10.56	-
Current Income Taxes Payable	12.87	25.83	19.29	39.65	17.34	15.88
Current Unearned Revenue	49.91	36.59	39.74	80.96	42.82	34.28
Other Current Liabilities	97.74	109.55	120.48	129.46	116.64	123.13
Total Current Liabilities	1,050	1,190	998.38	1,053	866.48	684.95
Long-Term Debt	-	-	12.37	17.33	7.28	-
Long-Term Leases	14.09	20.79	32.26	44.33	43.06	-
Long-Term Unearned Revenue	34.45	34.49	10.02	9.5	4.14	3.34
Long-Term Deferred Tax Liabilities	2.25	15.33	18.22	18.85	16.9	7.06
Total Liabilities	1,101	1,261	1,071	1,143	937.86	695.35
Common Stock	480	480	480	480	360	360
Additional Paid-In Capital	1,662	1,662	1,662	1,662	146.47	146.47
Retained Earnings	1,601	1,567	1,314	1,017	686.08	479.6
Treasury Stock	-176.19	-176.19	-	-	-	-
Comprehensive Income & Other	10.48	10.98	12.34	15.1	18.94	19.21
Total Common Equity	3,578	3,545	3,468	3,174	1,211	1,005
Minority Interest	12.13	11.53	8.12	4.55	3.83	2.4
Shareholders' Equity	3,590	3,556	3,477	3,179	1,215	1,008
Total Liabilities & Equity	4,691	4,817	4,548	4,322	2,153	1,703
Total Debt	32.46	75.16	124.3	122.92	137.99	83.77
Net Cash (Debt)	1,990	2,298	2,407	2,418	396.7	236.47
Net Cash Growth	-9.27%	-4.51%	-0.49%	509.62%	67.76%	55.60%
Net Cash Per Share	4.23	4.89	5.02	5.73	1.10	0.66
Filing Date Shares Outstanding	468	468	480	480	360	360
Total Common Shares Outstanding	468	468	480	480	360	360
Working Capital	1,818	2,011	2,330	2,319	412.94	388.89
Book Value Per Share	7.65	7.57	7.23	6.61	3.37	2.79
Tangible Book Value	3,439	3,405	3,318	3,032	1,067	951.52
Tangible Book Value Per Share	7.35	7.28	6.91	6.32	2.96	2.64
Buildings	1,173	523.07	520.3	506.03	443.93	307.44
Machinery	656.18	609.64	558.75	511.19	416.4	330.46
Construction In Progress	280.07	719.15	255.66	46.72	100.06	175.55

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.